Trust – Experience – Global Relationships – Results.
Discover why we are the investment bank of choice for life science businesses.
Biotech Alliances International, Inc. is a San Francisco based boutique investment bank serving life science companies, private equity and venture capital funds. You can depend on independent financial and strategic advice including corporate finance, mergers & acquisitions, partnering & licensing, deal sourcing and strategic consulting.
You’ll find that we are client-focused, candid and direct. We are industry specialists that simplify complex challenges. We believe in the potential of your business, and help you achieve your growth and liquidity goals.
HEALTHCARE SECTOR EXPERTISE
Our team leverages its broad industry experience and truly understand the landscape in the intersection of healthcare and technology.
IN THE NEWS
Oncgnostics GmbH Presents New Clinical Data on GynTect® Precision Diagnostics at EUROGIN 2018
SAN FRANCISCO, CA, USA, November 29, 2018 /EINPresswire.com/ — Oncgnostics GmbH presents new clinical data on GynTect® Precision Diagnostics for triage of unclear cervical cancer screening tests.[ READ FULL PRESS RELEASE ]
Enlyton LLC retains Biotech Alliances International Inc. to Lead $15m Series A Capital Raise
Enlyton, LLC., has developed a molecular biomarker for colon cancer, and other solid cancers.
SAN FRANCISCO, CALIFORNIA , October 8, 2018 /EINPresswire.com/ — Biotech Alliances International, a Silicon Valley-based healthcare-focused investment bank, announced today that it will serve as the lead investment banker to Enlyton LLC for its Series A $15m capital raise.[ READ FULL PRESS RELEASE ]
Oncgnostics GmbH retains Biotech Alliances International Inc. to lead global partnering and distribution strategy.
Cervical cancer is still a significant problem for patients and health care systems.
SAN FRANCISCO, CALIFORNIA, USA, October 2, 2018 /EINPresswire.com/ — Biotech Alliances International Inc., a Silicon Valley-based healthcare-focused investment bank, announced today that it will serve as the lead investment banker to Oncgnostics globalisation and partnering strategy.[ READ FULL PRESS RELEASE ]
Sealantium Medical retains Biotech Alliances International to Lead Series B $10 Million Capital Raise
Scientific advances in connection with a step increase in globalization of the life science industry at large make it absolutely necessary that even early stage companies think and act global. Servicing the United States, Europe and Asia, we provide region specific services to our international clients.
[ LEARN MORE ]